{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:45:00Z","timestamp":1776275100101,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ischemic strokes in young adults are often classified as cryptogenic when standard evaluation fails to identify an underlying cause. Growing evidence connects systemic inflammatory diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), to early-onset atherosclerotic cardiovascular disease (ASCVD) that is driven by proinflammatory cytokines and endothelial dysfunction. Hidradenitis suppurativa (HS), a chronic inflammatory skin condition marked by recurrent abscesses and sinus tracts, shares similar inflammatory pathways but remains underrecognized as a cardiovascular risk factor. We report the case of a 28-year-old active-duty service member who presented with acute ischemic stroke after prior transient visual disturbances. Initial evaluation, including vascular imaging, echocardiography, telemetry, autoimmune and coagulation testing, was unrevealing, and the stroke was labeled cryptogenic. At follow-up, advanced HS (Hurley stage III) was diagnosed, and treatment with adalimumab led to both dermatologic improvement and absence of further neurologic events. This case emphasizes HS as a possible cause of cryptogenic ischemic stroke because of chronic systemic inflammation. Recognizing HS as a systemic disease with cardiovascular and neurological effects is critical. Early diagnosis and prompt treatment may lower long-term morbidity, especially in young military populations where early vascular events have major personal and occupational consequences.<\/jats:p>","DOI":"10.1093\/milmed\/usag163","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:43:39Z","timestamp":1775043819000},"source":"Crossref","is-referenced-by-count":0,"title":["More Than Skin Deep: A Case of Stroke Secondary to Hidradenitis Suppurativa"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1201-8424","authenticated-orcid":false,"given":"Danielle","family":"Lacasse","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Naval Medical Center Portsmouth , Portsmouth, VA 23708,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngun Cer","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, George Washington University Hospital , Washington, DC 20037,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Otto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Naval Medical Center Portsmouth , Portsmouth, VA 23708,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Naval Medical Center Portsmouth , Portsmouth, VA 23708,","place":["United States"]},{"name":"Department of Medicine, Uniformed Services University , Bethesda, MD 20814,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026041512472972000_usag163-B1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/01.CIR.0000157736.19739.D0","article-title":"Ischemic stroke subtype incidence among whites, blacks, and hispanics","volume":"111","author":"White","year":"2005","journal-title":"Circulation"},{"key":"2026041512472972000_usag163-B2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1161\/STR.0b013e31825bcdac","article-title":"Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American heart association\/American stroke association","volume":"43","author":"Lackland","year":"2012","journal-title":"Stroke"},{"key":"2026041512472972000_usag163-B3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamaneurol.2024.0190","article-title":"Burden of ischemic and hemorrhagic stroke across the US from 1990 to 2019","volume":"81","author":"Renedo","year":"2024","journal-title":"JAMA Neurol"},{"key":"2026041512472972000_usag163-B4","author":"Centers for Disease Control and Prevention","year":"2025"},{"key":"2026041512472972000_usag163-B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","article-title":"Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2026041512472972000_usag163-B6","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.jaut.2022.102863","article-title":"Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus","volume":"132","author":"Liu","year":"2022","journal-title":"J Autoimmun"},{"key":"2026041512472972000_usag163-B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.05.008","article-title":"Cardiovascular disease in systemic lupus erythematosus: a comprehensive update","volume":"82","author":"Giannelou","year":"2017","journal-title":"J Autoimmun"},{"key":"2026041512472972000_usag163-B8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41584-023-00969-7","article-title":"Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease","volume":"19","author":"Weber","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026041512472972000_usag163-B9","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2026041512472972000_usag163-B10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2026041512472972000_usag163-B11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026041512472972000_usag163-B12","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J Invest Dermatol"},{"key":"2026041512472972000_usag163-B13","doi-asserted-by":"publisher","first-page":"2450401","DOI":"10.1155\/2017\/2450401","article-title":"Increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2026041512472972000_usag163-B14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"2026041512472972000_usag163-B15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin-17 serum levels in patients with hidradenitis suppurativa","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2026041512472972000_usag163-B16","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.3390\/ijms21228436","article-title":"Cytokine pathways and investigational target therapies in hidradenitis suppurativa","volume":"21","author":"Del Duca","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026041512472972000_usag163-B17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2026041512472972000_usag163-B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2026041512472972000_usag163-B19","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1080\/09546634.2021.1959502","article-title":"Hidradenitis suppurativa and association with stroke: systematic review and meta-analysis","volume":"33","author":"Phan","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2026041512472972000_usag163-B20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults","volume":"18","author":"Kwa","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"2026041512472972000_usag163-B21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000507323","article-title":"Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines","volume":"236","author":"Orenstein","year":"2020","journal-title":"Dermatology"},{"key":"2026041512472972000_usag163-B22","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/j.ajpc.2022.100335","article-title":"Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement","volume":"10","author":"Wong","year":"2022","journal-title":"Am J Prev Cardiol."}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article-pdf\/doi\/10.1093\/milmed\/usag163\/68087068\/usag163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article-pdf\/doi\/10.1093\/milmed\/usag163\/68087068\/usag163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:47:38Z","timestamp":1776271658000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article\/doi\/10.1093\/milmed\/usag163\/8654451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1093\/milmed\/usag163","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"usag163"}}